Global Cattle Vaccine Market Strategic Research Report

Scope of the Report

The global Cattle Vaccine market size is predicted to grow from US$ 1,832 million in 2025 to US$ 2,778 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

A cattle vaccine is a biological preparation designed to help cattle (both beef and dairy) develop immunity against specific infectious diseases.

It contains weakened, killed, or inactivated pathogens (or parts of them, such as proteins or toxins) that stimulate the cow’s immune system to recognize and fight the disease without causing the disease itself. In 2024, global cattle vaccines production reached approximately 160 million units, with an average global market price of around US$ 10.5 per unit.

Global outbreaks of infectious bovine diseases—such as Foot-and-Mouth Disease (FMD), Bovine Respiratory Disease Complex (BRDC), Brucellosis, and Bovine Viral Diarrhea (BVD)—are increasing vaccination adoption rates. These diseases can cause massive productivity and economic losses in the livestock industry, making preventive vaccination an essential part of herd management.

Increasing demand for high-quality beef and dairy products, especially in Asia-Pacific and Latin America, is pushing farmers to invest in vaccines to maintain herd productivity and product safety.

Many regions (e.g., EU, parts of South America, India) implement government-subsidized or mandatory cattle vaccination programs to control endemic diseases, ensuring market stability.

Development of recombinant DNA vaccines, subunit vaccines, and mRNA-based veterinary vaccines is accelerating, improving efficacy and reducing adverse reactions.

Multi-disease vaccines are gaining popularity for reducing labor costs and stress on animals during administration.

Especially important for developing countries, thermostable vaccines reduce dependency on cold chain logistics.

This report presents a comprehensive overview of the global Cattle Vaccine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Live Attenuated Vaccine
• Inactivated Vaccine
• Others

Segment by Sales Channel

• Government Bidding
• Market Sales

Segment by players, this report covers

• Merck Animal Health
• Zoetis
• Boehringer Ingelheim
• Ceva
• Zoetis
• Elanco Animal Health
• Indian Immunologicals
• Cambridge Technologies
• Vaxxinova
• Jinyu Bio-Technolog
• China Animal Husbandry Industry
• Tecon Biology

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cattle Vaccine market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in key end-use industries evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact